Literature DB >> 18986688

Dietary aspirin decreases the stage of ovarian cancer in the hen.

M E Urick1, J R Giles, P A Johnson.   

Abstract

OBJECTIVE: We aimed to determine the effects of dietary aspirin treatment on ovarian cancer incidence and progression in the hen as a model for the human disease.
METHODS: Hens were fed a standard layer diet (control) or the same diet containing 0.1% aspirin for 1 year. Liver prostaglandin E(2) (PGE(2)) was measured using an enzyme immunoassay. Incidence and stage of ovarian cancer were determined through necropsy and immunohistochemical analysis of ovarian sections for each hen.
RESULTS: Aspirin treatment decreased liver PGE(2) in treated hens as compared to control hens. Treatment with aspirin did not decrease ovarian cancer incidence. Significantly more control hens developed late stage ovarian cancer than early stage, while the same was not true for aspirin-treated hens. Hens that developed ovarian cancer, even early ovarian cancer, produced significantly fewer eggs in the year prior to diagnosis than hens without ovarian cancer.
CONCLUSIONS: Aspirin treatment may inhibit the progression of ovarian cancer in the hen and egg production may be used to identify hens with early stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18986688     DOI: 10.1016/j.ygyno.2008.09.032

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

1.  Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.

Authors:  Adam M Hawkridge; Rebecca B Wysocky; James N Petitte; Kenneth E Anderson; Paul E Mozdziak; Oscar J Fletcher; Jonathan M Horowitz; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2010-07-17       Impact factor: 4.142

Review 2.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

Review 3.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

4.  Gene expression profiling reveals differentially expressed genes in ovarian cancer of the hen: support for oviductal origin?

Authors:  Lindsey S Treviño; James R Giles; Wei Wang; Mary Ellen Urick; Patricia Ann Johnson
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

5.  Oral contraceptives decrease the prevalence of ovarian cancer in the hen.

Authors:  Lindsey S Treviño; Elizabeth L Buckles; Patricia A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

Review 6.  The chicken model of spontaneous ovarian cancer.

Authors:  Adam M Hawkridge
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

7.  The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21.

Authors:  Deok-Soo Son; Andrew J Wilson; Angelika K Parl; Dineo Khabele
Journal:  Cancer Biol Ther       Date:  2010-06-25       Impact factor: 4.742

8.  The hen as a model of ovarian cancer.

Authors:  Patricia A Johnson; James R Giles
Journal:  Nat Rev Cancer       Date:  2013-05-16       Impact factor: 60.716

9.  Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E₂in hens.

Authors:  Erfan Eilati; Janice M Bahr; Dale Buchanan Hales
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

10.  Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer model.

Authors:  Genna L Andrews Kingon; James N Petitte; David C Muddiman; Adam M Hawkridge
Journal:  Methods       Date:  2013-04-19       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.